Document is current
Any future updates will be listed below
-
Authors
Schmitt, Nanni https://orcid.org/0000-0003-3455-9606
Siegler, Jana-Julia
Beck, Alexandra
Müller, Thomas
Kozlowska, Izabela
Sarlang, Séverine
Reusch, Uwe
Knackmuss, Stefan
Medina-Echeverz, José
Koch, Joachim
Ross, Thorsten
Darwich, Ali https://orcid.org/0000-0001-9463-9638
Hoppe, Lea
Abba, Mohammed
Streuer, Alexander https://orcid.org/0000-0002-3531-534X
Klein, Stefan
Hofmann, Wolf-Karsten
Gündner, Anna Lisa
Merz, Christian
Endell, Jan
Pahl, Jens https://orcid.org/0000-0003-1083-794X
Nowak, Daniel https://orcid.org/0000-0001-7130-7921
-
Funding
Funding for this research was provided by:
Affimed GmbH; German José Carreras Foundation
- License Information
-
More Information
Article History
Received: 21 February 2024
Accepted: 8 August 2025
First Online: 21 August 2025
Competing interests
: This study was supported by funding from Affimed GmbH. J.P. is an employee of Affimed GmbH. J.J.S., S.S., U.R., J.M.E., J.K., A.L.G., T.R., T.M., I.K., SKnackmuss, C.M., and J.E. were employees of Affimed at the time of writing and execution of this study. D.N. has received research funding from Affimed, Tolero Pharma, Pharmaxis and Apogenix, received funding for a clinical trial from AbbVie and received honoraria from Celgene and Takeda. The remaining authors declare no competing interests.
